FindTrial
Sign In

Agreement of parathyroid scintigraphy interpretation with early and delayed SPECT in hyperparathyroidism patients

Agreement of parathyroid scintigraphy interpretation with early and delayed SPECT in hyperparathyroidism patients

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20221026006
Enrollment
118
Registered
2022-10-26
Start date
2022-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperparathyroidism Hyperparathyroidism Radionuclide imaging

Interventions

Patients with hyperparathyroidism
Diagnostic
Suject

Sponsors

Faculty of Medicine, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with (1) hyperparathyroidism who (2) undergo Tc-99m sestamibi parathyroid scans and have (3) available serum iPTH, calcium and albumin within 3 months within the scan dates

Exclusion criteria

Exclusion criteria: Patients who had (1) prior surgery to the neck,(2) allergic to radiotracers, or (3) pregnant or in lactation.

Design outcomes

Primary

MeasureTime frame
Agreement of early and delayed imaging at the 10th and the 90th minute after radiotracer injection Bimary outcomes (each images are interpreted as presence or absences of enlarged parathyroid gland)—

Secondary

MeasureTime frame
N/A N/A N/A—

Countries

Thailand

Contacts

Public ContactSira Vachatimanont

Faculty of Medicine, Chulalongkorn University

siravac@gmail.com0879179182

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026